Nitrogen → 2-(4-((2-(1-Aminoisoquinolin-4-yl)-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)piperazin-1-yl)-2-methylpropanamide

HRID 1922879Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1922879
Br[C:2]1[C:11]2[C:6](=[CH:7][CH:8]=[CH:9][CH:10]=2)[C:5]([NH2:12])=[N:4][CH:3]=1.C([O-])(=O)C.[K+].N#N.Cl[C:21]1[N:22]=[C:23]([N:43]2[CH2:48][CH2:47][O:46][CH2:45][CH2:44]2)[C:24]2[S:29][C:28]([CH2:30][N:31]3[CH2:36][CH2:35][N:34]([C:37]([CH3:42])([CH3:41])[C:38]([NH2:40])=[O:39])[CH2:33][CH2:32]3)=[CH:27][C:25]=2[N:26]=1.C(=O)([O-])[O-].[Na+].[Na+].C(P(C(C)(C)C)C(C)(C)C)(C)(C)C>O1CCOCC1.C(Cl)Cl.C1(C)C=CC=CC=1.C1C=CC(P(C2C=CC=CC=2)[C-]2C=CC=C2)=CC=1.C1C=CC(P(C2C=CC=CC=2)[C-]2C=CC=C2)=CC=1.Cl[Pd]Cl.[Fe+2].C([O-])(=O)C.[Pd+2].C([O-])(=O)C>[NH2:12][C:5]1[C:6]2[C:11](=[CH:10][CH:9]=[CH:8][CH:7]=2)[C:2]([C:21]2[N:22]=[C:23]([N:43]3[CH2:44][CH2:45][O:46][CH2:47][CH2:48]3)[C:24]3[S:29][C:28]([CH2:30][N:31]4[CH2:32][CH2:33][N:34]([C:37]([CH3:42])([CH3:41])[C:38]([NH2:40])=[O:39])[CH2:35][CH2:36]4)=[CH:27][C:25]=3[N:26]=2)=[CH:3][N:4]=1

Komponenten

12

Reaktionsbedingungen

Temperatur
80 °C

Versuchsvorschrift

A mixture of 4-bromoisoquinolin-1-amine (126 mg, 0.565 mmol), bispinacol ester boronate (358 mg, 1.41 mmol), and potassium acetate (333 mg, 3.39 mmol) in 1,4-dioxane (4.6 mL) was sparged with N2 for 10 min. [1,1′-bis(diphenylphosphino)ferrocene]dichloropalladium(II), complex with dichloromethane (1:1) (23.1 mg, 0.0282 mmol) was added. The mixture was sealed under N2 and heated at 80° C. for 20 h, diluted with DCM, the contents were filtered, washed with DCM, and concentrated. The crude product was mixed with 2-(4-((2-chloro-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)piperazin-1-yl)-2-methylpropanamide (124 mg, 0.282 mmol), a 1 M solution of sodium carbonate (0.85 mL) and 1,4-dioxane (3.4 mL, 44 mmol). The mixture was sparged with N2 for 10 min. Palladium acetate (6.342 mg, 0.02825 mmol) and a 1.0 M solution of tri-tert-butylphosphine in toluene (0.0565 mL) were added. The mixture was sealed under N2 and heated at 85° C. for 6 h, diluted with DCM, the contents were filtered, and concentrated. The residue was purified with flash chromatography. The fractions containing the desired product were collected, concentrated, and purified with reverse-phase HPLC to give 108 (25 mg, 16%). LCMS: M+H+=467. 1H NMR (400 MHz, CDCl3) δ 8.91 (d, J=8.6, 1H), 8.67 (s, 1H), 7.85 (d, J=8.3, 1H), 7.71-7.64 (m, 1H), 7.53 (t, J=7.3, 1H), 7.34 (s, 1H), 7.10 (s, 1H), 5.29 (s, 2H), 5.20 (s, 1H), 4.10-3.99 (m, 4H), 3.87 (dd, J=9.1, 4.6, 6H), 2.61 (s, 8H), 1.24 (s, 6H)

Aufarbeitung

  1. additionwas added
  2. customThe mixture was sealed under N2
  3. filtrationthe contents were filtered
  4. washwashed with DCM
  5. concentrationconcentrated
  6. customThe mixture was sparged with N2 for 10 min
  7. customThe mixture was sealed under N2
  8. temperatureheated at 85° C. for 6 h
  9. filtrationthe contents were filtered
  10. concentrationconcentrated
  11. customThe residue was purified with flash chromatography
  12. additionThe fractions containing the desired product
  13. customwere collected
  14. concentrationconcentrated
  15. custompurified with reverse-phase HPLC

Quellen und Nachweise

ORD-Eintrag
ord-162a3ec761e648cb8c693157bae7c8f3
Quelldatensatz
uspto-grants-2012_05
Patentnummer
US08173650B2

Notizen zur Reaktion

Wird geladen…